Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

PFIZER, INC.

(PFE)
  Report
Delayed Nyse  -  04:03:52 2023-02-06 pm EST
43.76 USD   -0.68%
03:07pDrug companies face huge drop in sales in 2023
RE
06:05aDrug companies face COVID cliff in 2023 as sales set to plummet
RE
02/02Pfizer, Ada Health to Launch COVID-19 Care Journey Platform
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Most relevant news about PFIZER, INC.
02/02Pfizer, Ada Health to Launch COVID-19 Care Journey Platform
MT
02/01US FDA Removes COVID-19 Test Requirement for Pfizer's Paxlovid
MT
02/01Morgan Stanley Adjusts Pfizer Price Target to $45 From $53, Maintains Equal Weight Rati..
MT
02/01SVB Securities Adjusts Pfizer's Price Target to $48 From $49, Keeps Market Perform Rati..
MT
02/01Atlantic Equities Adjusts Pfizer's Price Target to $46 From $50, Keeps Neutral Rating
MT
02/01Barclays Adjusts Pfizer's Price Target to $44 From $49, Keeps Equalweight Rating
MT
02/01BMO Capital Trims Price Target on Pfizer to $53 From $55, Maintains Outperform Rating
MT
02/01UBS Adjusts Pfizer's Price Target to $45 From $47, Maintains Neutral Rating
MT
02/01PFIZER INC : UBS gives a Neutral rating
MD
02/01Credit Suisse Lowers Pfizer's PT to $50 From $54 to Reflect Increasing Costs Required t..
MT
02/01First To File : Issue 9
AQ
02/01MassBio - Pfizer Pharma Day to ignite breakthrough partnerships
AQ
02/01PFIZER INC : JP Morgan remains Neutral
MD
01/31Drugmaker Pfizer starts low with 2023 earnings forecast
AQ
01/31Transcript : Pfizer Inc., Q4 2022 Earnings Call, Jan 31, 2023
CI
More most relevant news
All news about PFIZER, INC.
03:07pDrug companies face huge drop in sales in 2023
RE
06:05aDrug companies face COVID cliff in 2023 as sales set to plummet
RE
02/02Pfizer, Ada Health to Launch COVID-19 Care Journey Platform
MT
02/02Avalon GloboCare Partnerships, Completed Capital Raise, And Robust IP Portfolio Expose ..
AQ
02/02Merck fourth quarter tops expectations on strong COVID pill sales
RE
02/01Zhejiang Huahai Pharma to Supply APIs to Junshi Biosciences
MT
02/01US FDA Removes COVID-19 Test Requirement for Pfizer's Paxlovid
MT
02/01Analysis-GSK gives few clues on plans to replenish medicine cabinet
RE
02/01Morgan Stanley Adjusts Pfizer Price Target to $45 From $53, Maintains Equal Weight Rati..
MT
02/01SVB Securities Adjusts Pfizer's Price Target to $48 From $49, Keeps Market Perform Rati..
MT
More news
News in other languages on PFIZER, INC.
08:57aCronache di Borsa - Lunedì 6 Febbraio
02/03La china CanSino confía en que su vacuna COVID de ARNm sea tan buena como las de Modern..
02/03Cronache di Borsa - Venerdì 3 Febbraio
02/02Für die Medizinbranche ist der Corona-Boom vorbei
02/02Merck & Co rechnet mit schwächerem Jahr - Aktie unter Druck
02/02Cronache di Borsa - Giovedì 2 Febbraio
02/02Biontech investiert 40 Mio EUR in eigene Plasmid-DNA-Produktion
02/02Le quatrième trimestre de Merck dépasse les attentes grâce aux fortes ventes de pilules..
02/02Zahl stationärer Krebsbehandlungen auf tiefstem Stand seit 20 Jahren
02/02Dassault Systèmes prévoit une croissance du chiffre d'affaires en 2023, espère un rebon..
More news
Analyst Recommendations on PFIZER, INC.
02/01Morgan Stanley Adjusts Pfizer Price Target to $45 From $53, Maintains Equal Weight Rati..
MT
02/01SVB Securities Adjusts Pfizer's Price Target to $48 From $49, Keeps Market Perform Rati..
MT
02/01Atlantic Equities Adjusts Pfizer's Price Target to $46 From $50, Keeps Neutral Rating
MT
02/01Barclays Adjusts Pfizer's Price Target to $44 From $49, Keeps Equalweight Rating
MT
02/01BMO Capital Trims Price Target on Pfizer to $53 From $55, Maintains Outperform Rating
MT
More recommendations
Press releases
02/02Avalon GloboCare Partnerships, Completed Capital Raise, And Robust IP Portfolio Expose ..
AQ
02/01First To File : Issue 9
AQ
02/01MassBio - Pfizer Pharma Day to ignite breakthrough partnerships
AQ
01/31Drugmaker Pfizer starts low with 2023 earnings forecast
AQ
01/31Pfizer : Q4 Earnings Snapshot
AQ
More press releases
Upcoming event on PFIZER, INC.